Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) FCF Margin (2020 - 2026)

Bioventus filings provide 6 years of FCF Margin readings, the most recent being 25.15% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 1315.0% to 25.15% in Q4 2025 year-over-year; TTM through Dec 2025 was 13.1%, a 651.0% increase, with the full-year FY2025 number at 13.1%, up 651.0% from a year prior.
  • FCF Margin hit 25.15% in Q4 2025 for Bioventus, up from 21.37% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 25.15% in Q4 2025 to a low of 22.25% in Q2 2021.
  • Median FCF Margin over the past 5 years was 6.83% (2021), compared with a mean of 4.04%.
  • Biggest five-year swings in FCF Margin: plummeted -4437bps in 2021 and later skyrocketed 1757bps in 2024.
  • Bioventus' FCF Margin stood at 13.03% in 2021, then tumbled by -63bps to 4.84% in 2022, then soared by 112bps to 10.25% in 2023, then increased by 17bps to 11.99% in 2024, then skyrocketed by 110bps to 25.15% in 2025.
  • The last three reported values for FCF Margin were 25.15% (Q4 2025), 21.37% (Q3 2025), and 17.1% (Q2 2025) per Business Quant data.